ARS Pharmaceuticals (SPRY) Stock Chart & Stock Price History $16.66 +0.28 (+1.71%) Closing price 04:00 PM EasternExtended Trading$16.62 -0.04 (-0.21%) As of 04:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ARS Pharmaceuticals Stock Price Performance The ARS Pharmaceuticals (SPRY) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 53.55%, with a year-to-date return of 57.91%. In the past month, the stock has decreased 5.82%, reflecting recent market activity. As of the latest close, ARS Pharmaceuticals traded at $16.38 with a market cap of $1.61 billion and volume of 2.29 million shares. Receive SPRY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ARS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-5.61%1 Month Performance-5.82%3 Month Performance+25.36%Year-To-Date Performance+57.91%1 Year Performance+53.55% SPRY Stock Chart for Tuesday, August, 12, 2025 SPRY Chart by TradingView ARS Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/11/2025$17.50$16.38-6.40%$17.54$15.902.29 million shs$1.61 billion08/08/2025$17.65$17.50-0.85%$17.90$17.40715,574 shs$1.72 billion08/07/2025$17.98$17.65-1.84%$18.00$17.34741,271 shs$1.73 billion08/06/2025$17.80$17.98+1.01%$18.00$17.391.03 million shs$1.77 billion08/05/2025$17.38$17.80+2.42%$18.00$17.23942,910 shs$1.75 billion08/04/2025$17.18$17.38+1.16%$17.62$17.081.20 million shs$1.71 billion08/01/2025$17.68$17.18-2.83%$17.70$17.071.18 million shs$1.69 billion07/31/2025$17.88$17.68-1.12%$17.91$17.511.09 million shs$1.74 billion07/30/2025$17.75$17.88+0.73%$18.42$17.731.11 million shs$1.76 billion07/29/2025$18.35$17.75-3.27%$18.50$17.70728,716 shs$1.74 billion Get the Latest News and Ratings for SPRY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ARS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/28/2025$17.87$18.35+2.69%$18.63$17.782.06 million shs$1.80 billion07/25/2025$17.92$17.87-0.28%$18.05$17.412.73 million shs$1.76 billion07/24/2025$18.00$17.92-0.44%$18.16$17.701.29 million shs$1.76 billion07/23/2025$17.59$18.00+2.33%$18.17$17.431.15 million shs$1.77 billion07/22/2025$17.85$17.59-1.46%$18.00$17.52748,375 shs$1.73 billion07/21/2025$17.92$17.85-0.39%$18.15$17.61717,712 shs$1.75 billion07/18/2025$18.35$17.92-2.34%$18.61$17.751.34 million shs$1.76 billion07/17/2025$17.87$18.35+2.69%$18.44$17.751.81 million shs$1.80 billion07/16/2025$17.56$17.87+1.77%$17.99$17.57900,452 shs$1.76 billion07/15/2025$17.90$17.56-1.90%$18.00$17.19972,831 shs$1.72 billion07/14/2025$17.69$17.90+1.19%$18.22$17.61926,501 shs$1.76 billion07/11/2025$17.98$17.69-1.61%$18.05$17.461.11 million shs$1.74 billion Related Companies RYTM Stock Chart RNA Stock Chart NUVL Stock Chart AXSM Stock Chart CRSP Stock Chart MRUS Stock Chart ABVX Stock Chart VKTX Stock Chart TGTX Stock Chart ACAD Stock Chart Receive SPRY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ARS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SPRY) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredElon Musk: “Nothing happens without this…”Lithium has fueled the EV boom, but another resource is even more critical. Without it, over 20 million electr...Behind the Markets | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ARS Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access